GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development – an ...

Here are the most anticipated abstracts to keep an eye on going into the 2025 ASCO Gastrointestinal Cancers Symposium.

Clinical research tech firm Advarra has unveiled a new digital solution meant to help speed up study starts and facilitate ...

Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell therapies, sending the drug developer's shares down more than 4% in premarket ...

The French biotech company Nanobiotix announced today that it has dosed the first patient in the CONVERGE study, a Phase 2 ...

We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient centricity in terms of clinical trials and how the industry can navigate the ...

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...

CNTX has announced that the first patient has been dosed in its Phase 1 clinical trial evaluating CTIM-76. This experimental ...

Women's health experts explain why so many women have been using cycle syncing to optimize wellness at every phase of the month.

One of the biggest stories of last year was Lykos Therapeutics’ failure to get its MDMA candidate over the finish line for ...